Company

AuXin Surgery was incorporated in Belgium in January 2014 as a limited liability company. The Company is the pioneer of devices for chemically assisted dissection (CADISS® Method) in surgery. The objective is to make available to surgeons this novel method for use in many surgical procedures. The Company develops and sells complete CADISS® systems for targeted applications..

AuXin Surgery is ISO 13485 (2016) certified.

Management Team

DELCORPS Xavier

MARKETING DIRECTOR

x

VERJANS Benoît

MANAGING DIRECTOR

x

FERRIERE Laurent

QUALITY DIRECTOR

x

GORDENNE Valérie

CHIEF SCIENTIFIC OFFICER

x

Shareholders

Gilles Capart & Family

Business Angels

Angels.be

Collaborations

Scientific

Industrial

Belgian funding

European funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 882323.

News & Events

Congresses / Expert presentation – CADISS®

All
Congresses
Seminars
Next AuXin congresses
Distributor congresses
Press
Mai
19
2020

Hospitalar | São Paulo

CongressesNext Congresses
Mai
08
2020

Inter Disciplinary Spine Brussels 2020 | Brussels

CongressesNext Congresses
Jan
30
2020

22e Assises d’ORL | Nice

Congresses
Jan
27
2020

Arabhealth | Dubai

Congresses
Nov
29
2019

German distributor Vostra | DWG Kongress | Munich

Congresses
Nov
22
2019

Annual Congress ORL 2019 | Louvain-La-Neuve

Congresses
Oct
16
2019

Eurospine | Helsinki

Congresses
Oct
11
2019

60th annual conference of the Irish ENT society | Dublin

Congresses
Oct
10
2019

Nordics distributor Mediplast | Årsmøde Dansk Otokirurgisk Selskab | Nyborg

Congresses
Sep
28
2019

125ème congrès SFORL | Paris

Congresses

Careers